At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
HHHFNCdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Heated Humidified High-Flow Nasal Cannula During Six-Minute Walk Test in Patient With COPD Undergoing Pulmonary Rehabilitation
In Brief
A clinical study evaluating HHHFNC for COPD and 2 related conditions. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The aim of this study is to investigate the use heated humidified high-flow nasal cannula (HHHFNC) in pulmonary rehabilitation and analysis of cardiopulmonary parameters in adult patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOPD, Pulmonary Disease, Rehabilitation
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartMar 2019
Primary CompletionNov 2019
TodayJul 2026
First PostedMar 5, 2019
Enrollment StartMar 18, 2019
Primary CompletionNov 30, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.3 years ago
Interventions
HHHFNCdevice
HHHFNC setting: 1. Flow rate: 40L/min 2. FiO2: 0.4 HHHFNC will use immediately before 6MWT and remove at the end of 6MWT